The Ion Channel Biotechnology Centre (ICBC) was officially opened on Tuesday, 19th January 2010. The Centre works with the pharmaceutical industry to develop new drugs tackling conditions such as osteoarthritis and urinary incontinence.
Launch of Ion Channel Biotechnology Centre
The Ion Channel Biotechnology Centre (ICBC) was officially opened on Tuesday, 19th January 2010. The Centre works with the pharmaceutical industry to develop new drugs tackling conditions such as osteoarthritis and urinary incontinence.
The Centre has already secured €7.5 million in funding and is due to submit two patent applications in the first quarter of this year. It is one of 17 Enterprise Ireland-designated 'Applied Research Enhancement Centres' and works on commercialising technologies developed at Dundalk's Smooth Muscle Research Centre. Enterprise Ireland has contributed €2 million in funding for the development of chemistry and molecular biology facilities at the centre. The funding allowed a team of almost 20 scientists to develop novel drug molecules, optimise sophisticated imaging equipment for industry and support the commercial development of drugs for human and animal consumption.